We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
It's a very good question! I see a number of positives here: 1. Mgmt board includes some major heavy hitters rarely ever seen on an AIM tiddler (if you want to disagree, by all means do, but please state when you last saw a £50m mkt cap AIM share with folk like Harry Stratford on board!) 2. £50m mkt cap vs mkt valuation of other firms traded with stage 2 clinical trials passed and waiting for stage 3 3. We actually have a selling product in Amryt, as I understand it, so income generating, which in itself is incredible for such a tiny micro cap pharma from the online research I've been doing 4. Mkt potential looks MASSIVE for our main product, although it seems that 2018 is by far the earliest we might get approval As I see it the main risks/concerns that I have are: 1. Will we actually get approval in 2018 if that is the correct date (nothing's done in the pharma world until it's done!) 2. With the comparisons to a similar product which have been made about a company with a 500m mkt cap, why is Amryt listing via our cash shell rather than being snapped up by a major pharma player??? I'd love to hear folks views on this, positive and negative, because it leaves me scratching my head a bit. 3. If things go well, are we going to need a placing to raise more money for R&D costs or will this cash be sufficient? £10m to bring a potentially £B product to market seems microscopic - I'm sure I'm missing something hear, happy to get corrected by those with more knowledge in the sector (I've hitherto been primarily interested in technology and O&G AIM firms, but I like CF's presentation about pharma being a massive opportunity to multibag and am happy to have a small part of my self-invested portfolio here whilst the vast majority of it is tied up in a share which suffers from the usual AIM lack of transparency, poor communication and ongoing delays!)
Agreed! Why wait for the RTO? Buy in today at 3p and ride the wave on 19th with your shares re-listed at 24p. If that's what you think will happen post RTO!!!
what I do not understand is this: If the shares in issue today are the same as the shares to be in issue after the rto, why do folk think that those shares will go up on the day the rto is confirmed. Why do they not go up today ? Is it that there is a chance the rto may not happen? Or what ?
Yeah i wouldn't imagine a CEO saying. We did it so holders could gain more stock for support and help raise funds. All good though made total business sense imo.
At the Dublin Amryt meeting, Cathal explained in detail that they chose to resist early to allow private investors the opportunity to buy in pre RTO as opposed to inviting existing shareholders to take part in the placing...also, I think it re-lists on the 19th which is Tuesday, the vote is on the 18th
reason imo trading came back pre RTO was that part of the raise was funded by holders selling stock to gain more ie warrants. This has nearly or has dried up now. Probably helped raise a mill or two that way towards target.
also rubbish it will re list at 24p on admission imo. It will trade inline with where sp is on day before after conversion.
That is lunacy as is the base rate ii level. Its common post RTO or IPO etc to trade 20/30% above from the off. All about supply and demand. Its that simple.
Apologies, I meant: For that reason, there is no point buying 'above' 3p...
Hi AmoebaSon I was initially confused by this. The share will relist at 24p whatever the share price does in the interim. For that reason, there is no point buying under 3p unless you think it will climb sharply on day 1 of trading (19th) and there is a chance you wont get your entry price. My broker seems to think that we will get an indication of how well it will taken up by the market on day 1, by the price 1-3 days prior to re-listing. If it rises, the market is anticipating a rise above 24p (and vice versa) I too do not understand why it was not left suspended. This would have been much cleaner in my view. I would be interested to hear anyone else's views however. Thanks ThinIce
thanks wad. Im hoping for good things.
Im still confused by the RTO and the SP. So 8 to 1 consolidation meaning an opening of 24p yes? OK so what if we have massive buying today and the SP rises? does that mean that all the new buyers are buying at a premium? Say it rises to 4p - will it open after consolidation at 32p? If not then why did they stop the suspension and not just wait untill after the consolidation? Hey - a lot of questions sorry but just confused...
Don't Stop Believin'!
tightly to my shares here as we are entering an exciting journey this year. FAST & Furious!
Wad Decided to join the party here as gave being thinking about for while and took the plunge first thing
Of coverage this weekend in press. Great for a few to have a chance at same price as funds raised. 19th is looming now.
Wadnob = Ramper = Nob
Articles in both the Irish Sunday Business Post and Sunday Times about Amryt
Here to get in cheaper than raise participants imo. Should start getting interesting as 19th approaches.
Amryt Pharmaceuticals’ Episalvan could have “significant commercial success”, says boss https://www.youtube.com/watch?v=iDThKiratKY
Hadn't been to the Burlington aka Doubletrees in year it was like entering an airport in America.
Yep you just described a startup! Episalvan has potential but as of now still has no sales. I too was at the shareholder meeting and yes it was very professional so we will see over the next 18 months if they get fda approval for treatment of children with this terrible disease.
a startup is a business literally starting from scratch if you did your research on this company and what its acquired.. you'd know they are far from start ups..... one has a drug has been approved by Europe for marketing for particular type of burns. The same med has passed phase 2 for particular orphan (nasty) disease related to the skin. They've also acquired a company that has product revenues of nearly $1m you define such businesses as start ups ?
Nice summary, will keep an eye out for the presentation
Thanks very much for reporting back.